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Atrial ﬁbrillationThe gap junctions (GJs) formed by Cx40 and Cx43 provide a low resistance passage allowing for rapid
propagation of action potentials. Sporadic somatic mutations in GJA5 (encoding Cx40) have been
identiﬁed in lone atrial ﬁbrillation (AF) patients. More recently germline autosomal dominantly
inherited mutations in GJA5 have been found in early onset lone AF patients in several families over
generations. Characterizations of these AF-linked Cx40 mutants in model cells and in patient tissues
revealed that some of the mutants reduced GJ channel function due to an impaired trafﬁcking or
channel formation. While others showed a gain-of-function in hemichannels. These functional
alterations in GJs or hemichannel may play an important role in the pathogenesis of AF in the
mutant carriers.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction diseases, which are categorized as lone (or idiopathic) AF. There isAtrial ﬁbrillation (AF) is the most common sustained cardiac
arrhythmia. The prevalence of AF increases drastically with aging,
from about 1% in the general population to nearly 10% in people
over 80 years. Millions of people worldwide are presently affected
with AF and the ﬁgure is predicted to triple by 2050 [1,2]. Rapid
and erratic electrical activities in the atrial myocardium of AF
patients lead to an impairment of contractility of atria, which
increases cardiac morbidity and mortality [3,4]. The most devastat-
ing consequence of AF is that the stagnant blood pooling in the at-
ria promotes thrombosis and is a leading cause of embolic stroke
[5,6]. It’s been estimated that AF is responsible for approximately
15% of strokes [3,4,6]. The social-economic burden of AF is very
high, however, our knowledge on the mechanisms of the genera-
tion and perpetuation of AF is limited. AF has been traditionally
regarded as an acquired disease secondary to many common car-
diovascular diseases such as diabetes, hypertension, heart failure,
valvular diseases and myocardial infarction, which often lead to
structural changes favoring reentrant arrhythmias in atria [7].
However, some AF patients do not have any identiﬁable underlyinga great interest in deﬁning the genetic factors responsible for lone
AF, as these factors provide mechanistic insights on AF. Recent
studies in sporadic and familial AF patients identiﬁed mutations
in the genes encoding ion channels, transporters, Ca2+ handling
proteins, structural proteins, transcription factors and gap junc-
tions [7–13]. Here I review some recent advances on genetic and
functional studies of AF-linked gap junction mutants. Gap junction
channels located at the intercalated disks between myocytes are
the key channels to mediate the rapid action potential propagation
between cardiomyocytes.2. Molecular components and structure of gap junction
channels
Gap junction channels are intercellular channels, providing a
direct passage for ions and small molecules (up to about 1 kDa in
size) between adjacent cells. Each gap junction channel is formed
by end-to-end docking of two hemichannels called connexons.
Hemichannels are homo- or hetero-oligomeric proteins of 21
homologous connexins (Cxs) [14]. All Cxs share similar structural
topology with four transmembrane domains (M1–M4) linked by
two extracellular loops (E1 and E2) and one cytoplasmic loop (CL)
with both amino-terminus (NT) and carboxyl-terminus (CT)
residing in the cytoplasm (Fig. 1A). Experimental evidence suggests
that the amino terminus of several Cxs folds into the plasma
Fig. 1. Gap junction nomenclature and localization in the heart. (A) Topology model
for Cx40 to show 4 transmembrane domains (M1–4), 2 extracellular loops (E1 and
E2), amino terminus (NT) and carboxyl terminus (CT). (B) Cartoon models of gap
junction channels and their nomenclature. Hemichannels can be homomeric or
heteromeric and gap junction (GJ) channels can be homotypic or heterotypic. (C)
Cardiac connexins and their localization in the heart. SA, sino-atrial node, AV, atrio-
ventricular node; VCS, the ventricular conduction system including His bundle,
bundle branches, and Purkinje ﬁbres. Cartoon drawing illustrates the localization of
gap junction channels at the intercalated disks between cardiomyocytes and
hemichannels on the plasma membrane.
D. Bai / FEBS Letters 588 (2014) 1238–1243 1239membrane to form part of the gap junction pore inner surface
[15–18]. Six identical or different connexins oligomerize to form a
homomeric or heteromeric hemichannel, respectively [19].
Depending on the component hemichannel type, gap junction
channels can be homotypic or heterotypic (Fig. 1B). Each Cx has its
own tissue distribution and each cell usually expresses one or more
Cxs [19]. The main physiological function of gap junctions is to
synchronize neighbouring cells electrically and/or metabolically.
3. Gap junction subtypes in the heart
Cx40, Cx43 and Cx45 are found in the cardiomyocytes of the hu-
man heart [20–23]. Their distributions in different structures of the
human heart are illustrated in Fig. 1C. Both Cx40 and Cx43 are
abundantly expressed in atria and the ventricular conduction
system (VCS), while Cx43 is the dominant connexin in the ventri-
cles. Co-expression of Cx40 and Cx43 in the atria raises theoretical
possibility of forming heteromeric and/or heterotypic GJ channels.
Experimental evidence suggests that Cx43 and Cx40 appear to be
able to form heteromeric gap junction channels: (1) Cx40 and
Cx43 can be co-immunoprecipitated [24,25]. (2) pH-sensitive
gating was increased when Cx40 and Cx43 were co-expressed[26]. (3) Complex single channel conductance levels were observed
when expressing both Cx40 and Cx43 in each of the cells in a gap
junction linked pair [24,25,27]. Therefore, mutations in Cx40 or
Cx43 may cause impairment in the gap junction coupling in car-
diac tissues expressing both of these Cxs. It is predicted that
Cx40 hemichannel and Cx43 hemichannel may dock together to
form heterotypic gap junction channels in the atrial myocardium.
However, conﬂicting results were obtained regarding whether
the heterotypic Cx40/Cx43 GJ channel is functional [28–31].
Cx45 is highly enriched at the nodal areas (both SA and AV
nodes) and also at a low level in both atria and ventricles
[21–23,32–34]. Therefore the action potentials in the heart likely
propagate from the SA node through heterotypic gap junctions
Cx45/Cx40 or Cx45/Cx43 to atrial tissue and then through Cx40
(or Cx43)/Cx45 at the AV node (Fig. 1C). Mutations in Cx40 or
Cx43 may also affect the heterotypic gap junctions between these
Cxs [28–30]. Cx31.9 has been proposed to be in the nodal areas, but
no detectable level of expression was conﬁrmed [35].4. Gap junction hemichannels
Accumulating experimental evidence suggests that undocked
hemichannels can open transiently under certain cellular stresses,
for example, prolonged membrane depolarization, reduced extra-
cellular Ca2+ concentration, intracellular calcium over load and/or
mechanical stress [36–39]. Several common heart diseases, such
as myocardial ischemia, cardiomyopathy and hypertension, can
provide one or more of these cellular stresses to cardiomyocytes
to open connexin hemichannels [39–42]. Once they are open, ions
and small molecules can permeate through these hemichannels
according to their own electrochemical gradients [39,43]. Most of
the cardiac connexins have been shown to have putative hemi-
channel activities [21,43,44] or the potential [45]. Several potential
detrimental consequences may be associated with connexin hemi-
channel activities. (1) These extremely leaky hemichannels can
serve to provide an electrical ‘shunt’ to gap junction-coupled
cells/tissues to reduce/uncouple gap junction-mediated synchro-
nized activities similar to what was observed in the motoneurons
of the mollusc Navanax [46,47], where chemical synapses near
the site of coupling change the input resistance to uncouple the
motoneurons [47]. (2) Active hemichannels can also lead to a loss
of cellular homeostasis of ionic distribution, which is vital for excit-
able cells to keep a stable resting membrane potential and excit-
ability. (3) Excessive and prolonged increase in intracellular
calcium load and/or release/loss of intracellular ATP and other
hemichannel permeable signalling/metabolic molecules can play
a role in promoting osmotic imbalance, cell swelling and cell death.
Indeed, Cx43 hemichannels located at the cell membrane open un-
der ischemic conditions and may be partially responsible for cell
death [48–50]. More interestingly, the hemichannel blockers,
including GAP26, can reduce ischemia-induced infarction size
[51], indicating a role for hemichannels in ischemia-induced cell
death [48,52]. In addition to these potential detrimental effects
of hemichannels, hemichannels could play a role in the scaffolding
in the perinexus of the intercalated disks and/or ephaptic coupling
[53–56]. Several human disease-linked Cx mutants have been
shown to have decreased or increased hemichannel function,
which is thought to play a role in the etiology of the disease
[57,58]. However, it is largely unknown if defects in Cx40 and/or
Cx43 hemichannels can play a role in cardiac arrhythmias.5. Gap junction remodeling and cardiac arrhythmias
The function of the heart is to pump blood through the circula-
tory system. During diseased states, such as myocardial ischemia,
Fig. 2. Atrial ﬁbrillation-linked Cx40 mutants. A topology model of Cx40 with all
identiﬁed Cx40 mutants. Three somatic mutations (green balls) were found in the
atrial tissues from 3 lone AF patients (2 carrying P88S and the other one with both
G38D and M163V). Six autosomal dominantly inherited germline mutants (red
balls) were identiﬁed in early onset lone AF patients in several families. The number
of patients associated each mutants are: Q49X, 7; I75F, 2; V85I, 3; A96S, 2; L221I, 3;
L229M, 2. Data obtained from the following references [96–101].
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the heart is challenged by one or several pathological stress factors,
such as ischemia, infarction, mechanical pressure, volume overload
and aberrant electrical activation. The heart undergoes an adaptive
process known as remodeling [10] to compensate for the changes
caused by these stress factors. Gap junction remodeling is a key
component of this cardiac remodeling process, including decreased
connexin abundance, lateralized distribution of Cxs away from the
intercalated disks (which is predicted to decrease the coupling at
the intercalated disks and may also increase unpaired hemichannel
abundance), and changes in the phosphorylation status [9,59,60].
Atrial ﬁbrillation is due to abnormal impulse initiation and/or con-
duction [12,61]; the latter is believed to be much more frequent in
clinical cases [61], indicating the importance of maintaining a rapid
conduction. The conduction velocity is determined primarily by
cardiomyocyte excitability and the gap junction coupling conduc-
tance (Gj) [61,62]. Cardiac disease-linked gap junction remodeling
can decrease Gj between myocytes and increase the junctional de-
lays between cardiomyocytes. Repetitive ﬁring large amplitude ac-
tion potentials (100 mV) and an increase in the junctional delay
(increase the dwell time of large voltage across the gap junctions)
can trigger another prominent property of all cardiac gap junction
channels, i.e. transjunctional voltage-dependent gating (Vj-gating)
[25,27–30,44,63–66], which leads to a further decrease in the Gj
[63] in affected areas of the heart. Regional decrease in the Gj in-
creases the heterogeneity in action potential conduction velocity,
which is considered to be a key factor in promoting reentrant
arrhythmias [61,67]. The exact role of gap junctions or hemichan-
nels in generating a higher incidence of arrhythmias in many com-
mon heart diseases is not clear.
6. Atrial ﬁbrillation-linked connexin mutations and
mutant/knockout mouse models
6.1. GJA1/Cx43
Germline deletion of the Cx43 gene (Gja1) in mice leads to peri-
natal lethality due to developmental cardiac malformation [68]. In
contrast, mice with cardiac-restricted inactivation of Cx43 are via-
ble, but they develop ventricular tachyarrhythmias leading to sud-
den cardiac death within the ﬁrst two months of life [69,70]. Over
70 mutations in the gene GJA1 (encoding Cx43) are linked to ocu-
lodentodigital dysplasia (ODDD) where patients exhibit develop-
mental defects in the eyes, teeth, terminal digits and several
other abnormalities including heart defects [71–74]. Most of them
are missense point mutations causing single amino acid substitu-
tions in the Cx43 polypeptide. Functional studies have revealed
that ODDD-linked Cx43 mutants are often impaired in electrical
coupling [75–77]. A mutant mouse (Gja1Jrt/+) which harbors a
mutation (G60S) in Cx43, was found to possess many of the same
classical phenotypic features of ODDD [78] and displays an in-
creased vulnerability for atrial arrhythmias [79]. Another mouse
model of ODDD (Cx43G138R/+) displayed severe spontaneous/
inducible ventricular tachycardia associated with death within
6 months after birth [40]. Functional characterizations of Cx43
G138R indicated an impairment of gap junction and an enhanced
hemichannel function [40,75,77,80]. Non-ODDD-associated Cx43
mutants have recently been reported to be linked to cardiac
arrhythmias, for example, a somatic Cx43 frame shift mutant
(311FS) was found to associate with a sporadic case of AF [81];
two Cx43 mutations (E42K, S272P) were linked to sudden infant
death syndrome likely due to ventricular tachycardia [82]. Charac-
terization of these Cx43 mutants in vitro showed impaired gap
junction function and dominant negative action on wild-type con-
nexins [81,82]. An artiﬁcially created truncation mutation to deletethe last ﬁve amino acid residues (a PDZ binding domain) in the
C-terminus of Cx43 was found to generate ventricular arrhythmias
but not affecting the Gj [83]. Conversely, introducing a C-terminus
mimetic peptide of Cx43 was found to reduce arrhythmias in mice
[84]. These experimental evidence suggests an important role of
Cx43 in cardiac arrhythmias.
6.2. GJA5/Cx40
Mice lacking the gene encoding Cx40 are viable to adult age
with slowed atrial conduction velocity and increased vulnerability
of atrial arrhythmias [85–87]. However, more recent studies indi-
cated an increased conduction velocity and a decrease in the con-
duction heterogeneity was associated with the Cx40 knockout
mice [88–90], questioning the roles of Cx40 in mouse atrial
arrhythmias. The ﬁrst AF-linked Cx40 mutant (A96S) mouse has
just been generated and showed decreased conduction velocity
and prolonged the durations of induced atrial arrhythmias [91],
indicating an important role of Cx40 in mouse atrial arrhythmias.
In human studies, several lines of evidence indicate that the ge-
netic variants in the promoter/regulatory regions of the Cx40 gene
(GJA5) can reduce the abundance of Cx40 expression and are linked
to AF [92–95]. Sporadic somatic mutations and a germline muta-
tion in the coding region of the Cx40 gene were identiﬁed in a
group of lone AF patients [96,97] (Fig. 2). Functional studies on
these Cx40 mutants indicated that impairment in either the distri-
bution and/or function of the mutant gap junction channels may
predispose the patients to AF [96]. Recently, Yang and colleagues
identiﬁed ﬁve germline autosomal dominant mutations in GJA5
in lone AF patients, predicted to cause amino acid residue substitu-
tions of I75F, P85I, L221I and L229M, and one truncation mutation
(Q49X), which lost the majority of the peptide (Fig. 2) [98–100].
These mutations co-segregated completely with AF in the families
Table 1
Functional characteristics of AF-linked Cx40 mutants.
AF-linked Cx40 mutants Gap junction function Hemichannel function Possible mechanisms References
Mutant alone Mutant on w.t. Cx40 Mutant on w.t. Cx43
G38D Reduced n.t.* n.t. n.t. Impaired localization [96]
Q49X Eliminated Reduced Reduced Normal§ ER retention [101,102]
I75F Eliminated Reduced Reduced Normal Channel impairment [100,102]
V85I Normal n.t. Normal Enhanced Unknown [102]
P88S Eliminated Reduced Reduced n.t. Impaired localization [96]
A96S Reduced Reduced Reduced n.t. Channel impairment [96]
M163V Normal n.t. n.t. n.t. [96]
L221I Normal n.t. Normal Enhanced Unknown [102]
L229M Normal Normal Reduced Normal Transdominant on Cx43 Gj [100,102]
* n.t., not tested.
 Data obtained from studies using in vitro expression of the mutants in HeLa, N2A and/or Xenopus oocytes.
§ Normal, denotes no apparent differences were observed comparing to those of wild-type Cx40 GJ channel and/or hemichannel under the experimental conditions.
 Data obtained with propidium iodide uptake assay in the divalent cation free medium [102].
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jects [98–100]. Characterizations of these mutants revealed differ-
ent defects. Q49X showed a complete elimination of GJ plaques at
the cell–cell interfaces [101] and co-localization of Q49X with
intracellular organelle residential proteins suggest that Q49X was
trapped in the endoplasmic reticulum (ER). Interestingly that
Q49X also reduced the localization of wild-type Cx40 and Cx43
to the cell–cell interfaces and their Gj [101]. In contrast to Q49X,
all other AF-linked germline mutants (I75F, V85I, A96S, L221I
and L229M) did not show any major defects in the localization
and formation of GJ plaques at the cell–cell interfaces
[96,100,102]. However, dual patch clamp studies indicated that
both I75F and A96S virtually eliminated Gj in cell pairs expressing
these mutants [96,100]. When these mutants were co-expressed
with wild-type Cx40 or Cx43, the Gjs were also signiﬁcantly re-
duced [96,100], indicating that these mutants possess both domi-
nant negative and transdominant negative properties. In contrast,
the expression of V85I, L221I or L229M in N2A cell pairs did not
show any reduction of the Gj, indicating an apparently normal GJ
coupling of these mutants. Further investigations revealed that
L229M, but not V85I and L221I, displayed a transdominant nega-
tive action on the Gj of co-expressed Cx43 [100,102]. These studies
indicate that many of the AF-linked Cx40 mutants showed impair-
ment of GJ channels via different mechanisms (Table 1), whichmay
play a role in promoting atrial arrhythmias leading to AF.
As discussed earlier that undocked hemichannels can exist on
the cell plasma membrane and may play a role in the pathogenesis
of several disease-linked connexin mutations. To test hemichannel
function of the AF-linked germline Cx40 mutants, especially those
without any detectable changes in GJ function (V85I and L221I),
propidium iodide (PI)-uptake assay under divalent cation free con-
dition was used [102]. Interestingly, expressing either V85I or
L221I in HeLa cells showed a prominent PI-uptake while Cx40
and other AF-linked germline Cx40 mutants failed to display PI-up-
take, indicating an enhanced hemichannel function of these two
AF-linked mutants [102] (Table 1). A gain-of-function in hemichan-
nel activities of AF-linked Cx40 mutants revealed a novel possible
mechanism for the AF pathogenesis. One of the AF-linked somatic
mutant G38D was also reported to show increased hemichannel
activity [103]. It is also noted that mutation in Cx40 can link to
other cardiac disease, e.g. Cx40 Q58L has been reported to associ-
ate with progressive familial heart block type I [104].
7. Conclusions and limitations
Six germline and three somatic mutations in GJA5/Cx40 as well
as one somatic mutation in GJA1/Cx43 have been identiﬁed in 23
lone AF patients so far (Fig. 2). Characterizations of these mutantsin vitro revealed that they displayed various impairments in both
the GJ and/or hemichannel function. The impairment of the GJ
function in these mutants is predicted and could be due to abnor-
mal trafﬁcking or channel defects in the mutant or mutant-con-
taining GJs. Hemichannel gain-of-function on a few mutants is
interesting/surprising and points to a possible novel mechanism.
The combination of genetic and functional studies reveals that
mutations in the genes encoding gap junction channels are associ-
ated with lone AF and the underlying mechanisms are different de-
pended on the mutation. More detailed systematic research on
individual mutants is required to develop speciﬁc effective strate-
gies to restore a normal GJ/hemichannel function. Although Cx40
mutants are rare in AF cases, revealing the underlying mechanisms
will help us in understanding one of the key pathogenic factors
leading to common AF and developing treatment strategies. It is
very exciting to learn that viral introduction of wild-type atrial
connexins is very effective in treating pig models of AF [105,106].
Delineating the molecular and cellular mechanisms on Cx40
mutants leading to ﬁbrillating atria is critical in establishing a
causal relationship of these mutants to AF. Yet we are limited by
available research tools, approaches and biopsied tissues to do
the ‘ideal’ experiments. Currently the research on these mutants
are largely rely on well-established GJ-deﬁcient model cells (HeLa,
N2A cells or Xenopus oocytes), where it is possible to design exper-
iments to test the functional outcomes of expressing mutant alone,
mutant with wild-type Cxs in the same cell (possible heteromeric
channels) or in different cells (e.g. heterotypic pair). Due to voltage
clamp errors in highly coupled cell pairs (often the case in cardio-
myocytes) [70,107,108], lack of good cardiac tissue preparation for
gap junction function measurement [70] and other technical
challenges dealing with cardiomyocytes, researchers are rarely
addressing GJ questions using these preparations. Fortunately
mouse genetic model to carry AF-linked Cx40 mutant has been
developed, A96S, and shown to slow down the conduction
velocity and increased the duration of atrial tachycardia [91], all
consistent and predicted from the defects obtained from the
in vitro studies [96].Author contribution
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